Journal
Bone Marrow Transplantation
Publication Date
5-15-2019
Volume
54
Issue
11
First Page
1868
Last Page
1880
Document Type
Open Access Publication
DOI
10.1038/s41409-019-0451-2
Rights and Permissions
Kansagra, A.J., Frey, N.V., Bar, M. et al. Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT). Bone Marrow Transplant 54, 1868–1880 (2019). doi.org/10.1038/s41409-019-0451-2 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Kansagra, Ankit J; Ghobadi, Armin; and et al, "Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-An expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)." Bone Marrow Transplantation. 54, 11. 1868 - 1880. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/11757
